Patients with acute low back pain (LBP) who got opioids or gabapentinoids as initial therapy faced twice the risk of opioid ...

The FDA on Monday approved the first generic of the once-weekly estradiol and levonorgestrel transdermal system (Climara Pro) ...

Unintentional napping was associated with a higher incidence of possible or probable dementia, data from the National Health ...

All patient instructions should meet that standard. But with AI, getting the standard right becomes more urgent: it can ...

Former MIT biologist David Sabatini, PhD, was awarded $6 million in a sexual harassment defamation suit. (New York T ...

Remission, both in the original trial and the follow-up, was defined as a Disease Activity Score (DAS) less than 1.6; this ...

Exhaled sphingolipids appeared to distinguish between idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis, potentially offering a path toward noninvasive testing, researchers ...

Roughly a quarter of active-duty U.S. Army men had a single morning testosterone concentration under 300 ng/dL, a commonly used cutoff for low testosterone. (JAMA) Nearly half of American women ages ...

A group of Democratic senators is demanding that the federal agency overseeing Medicaid institute tougher standards for ...

One-year results from the open-label extension of the phase III MINT trial presented at the American Association of ...

The FDA said Edwards Lifesciences pulled its Commander M delivery systems for Sapien M3 transcatheter mitral valve ...

A novel exosome-based immunomodulatory agent appeared promising in speeding recovery from acute respiratory distress syndrome (ARDS), a phase IIb trial showed. The inhaled therapy substantially ...